COX-2 inhibition: a possible role in the management of prostate cancer?
There is mounting evidence to support a role for cyclooxygenase-2 (COX-2) inhibitors (coxibs) in the management of prostate cancer. This review considers the current evidence base for the use of coxibs in prostate cancer as well as their adverse event profile. A systematic literature review using th...
| Auteurs principaux: | , , , |
|---|---|
| Format: | Journal article |
| Langue: | English |
| Publié: |
2007
|